Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Infertility Drugs Market, by region, 2019-2029 (USD Billion)
1.2.2. Infertility Drugs Market, by Drug Class, 2019-2029 (USD Billion)
1.2.3. Infertility Drugs Market, by End User, 2019-2029 (USD Billion)
1.2.4. Infertility Drugs Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Infertility Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Infertility Drugs Market Dynamics
3.1. Infertility Drugs Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Upsurge in Healthcare Awareness along with Increasing Aging Female Population
3.1.1.2. Growing Prevalence of Stress and Life-style Disorders among Men and Women
3.1.2. Market Challenges
3.1.2.1. Strict Regulatory Structure that Impedes the Approval of Products
3.1.3. Market Opportunities
3.1.3.1. Rising incidences of infertility and miscarriage
3.1.3.2. Increasing public funding for developing these drugs
Chapter 4. Global Infertility Drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Infertility Drugs Market, by Drug Class
6.1. Market Snapshot
6.2. Global Infertility Drugs Market by Drug Class, Performance - Potential Analysis
6.3. Global Infertility Drugs Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
6.4. Infertility Drugs Market, Sub Segment Analysis
6.4.1. Gonadotrophins
6.4.2. Aromatase Inhibitors
6.4.3. Selective Estrogen Receptor Modulators (SERMs)
6.4.4. Biguanides
6.4.5. Other Drug Classes
Chapter 7. Global Infertility Drugs Market, by End User
7.1. Market Snapshot
7.2. Global Infertility Drugs Market by End User, Performance - Potential Analysis
7.3. Global Infertility Drugs Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
7.4. Infertility Drugs Market, Sub Segment Analysis
7.4.1. Male
7.4.2. Female
Chapter 8. Global Infertility Drugs Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Infertility Drugs Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Infertility Drugs Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
8.4. Infertility Drugs Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Other Distribution Channels
Chapter 9. Global Infertility Drugs Market, Regional Analysis
9.1. Infertility Drugs Market, Regional Market Snapshot
9.2. North America Infertility Drugs Market
9.2.1. U.S. Infertility Drugs Market
9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
9.2.1.2. End User breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Infertility Drugs Market
9.3. Europe Infertility Drugs Market Snapshot
9.3.1. U.K. Infertility Drugs Market
9.3.2. Germany Infertility Drugs Market
9.3.3. France Infertility Drugs Market
9.3.4. Spain Infertility Drugs Market
9.3.5. Italy Infertility Drugs Market
9.3.6. Rest of Europe Infertility Drugs Market
9.4. Asia-Pacific Infertility Drugs Market Snapshot
9.4.1. China Infertility Drugs Market
9.4.2. India Infertility Drugs Market
9.4.3. Japan Infertility Drugs Market
9.4.4. Australia Infertility Drugs Market
9.4.5. South Korea Infertility Drugs Market
9.4.6. Rest of Asia Pacific Infertility Drugs Market
9.5. Latin America Infertility Drugs Market Snapshot
9.5.1. Brazil Infertility Drugs Market
9.5.2. Mexico Infertility Drugs Market
9.6. Rest of The World Infertility Drugs Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Teva Pharmaceuticals Industries
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Abbott Laboratories
10.2.3. Mankind Pharma
10.2.4. Merck KGaA
10.2.5. Ferring Pharmaceuticals Inc.
10.2.6. Novartis International AG
10.2.7. Livzon
10.2.8. Pfizer Inc.
10.2.9. Theramex
10.2.10. Bayer AG
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption